and patient monitoring systems. Valued at $38.7 billion by market cap, GE HealthCare is poised to announce its fiscal Q4 earnings 2024 before the market opens on Thursday, Feb. 13. Ahead of this ...
The potential impact of SIGNA MAGNUS on patient outcomes and our understanding ... clearance from the US FDA for its Portrait vital signs monitor (VSM). "GE HealthCare unveils SIGNA MAGNUS for ...